ST
GILD icon

Sphinx Trading’s Gilead Sciences GILD Stock Holding History

Sphinx Trading’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,093
Closed -$86K – 108
2016
Q3 		$86K Sell
1,093
-2,620
-71% -$213K 0.18% 55
2016
Q2 		$310K Buy
+3,713
New +$330K 0.62% 17
2016
Q1 		– Sell
-4,801
Closed -$433K – 118
2015
Q4 		$486K Buy
4,801
+1,531
+47% +$159K 0.67% 23
2015
Q3 		$321K Sell
3,270
-10,771
-77% -$1.2M 0.34% 31
2015
Q2 		$1.64M Sell
14,041
-17,848
-56% -$1.95M 1.83% 13
2015
Q1 		$3.13M Sell
31,889
-98,932
-76% -$10M 4.39% 6
2014
Q4 		$12.3M Buy
+130,821
New +$13.5M 10.03% 4

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sphinx Trading's GILD Position: Q4 2016 in Review

Sphinx Trading sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 1,093 shares — an estimated $86K sold.

Sphinx Trading first reported a position in GILD in Q4 2014 and held it in 7 quarters. The position peaked at $12.3M in Q4 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Sphinx Trading reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Sphinx Trading sold 1,093 Gilead Sciences shares in Q4 2016, an estimated $86K.
  • Sphinx Trading first reported a position in Gilead Sciences in Q4 2014 and held it in 7 quarters.
  • Sphinx Trading's Gilead Sciences position peaked at $12.3M in Q4 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Sphinx Trading's 13F filing for Q4 2016, filed 24 Jan 2017.